[ad_1]
The right-wing president has again begun to minimize the pandemic, with a death toll from coronavirus in Brazil close to 100,000. – This is the second highest number of deaths in the world, second only to the United States.
After three weeks in quarantine after being infected with the coronavirus, Bolsonaro set out to show himself as an example. “I belong to a high-risk group,” the 65-year-old president told reporters during a visit to the southern state of Rio Grande.
“I knew that someday I would get it because I think almost everyone here will eventually get it.” What were you afraid of? Reconcile with him, said the president. – I regret the deaths, but people die every day, for many reasons. This is life.”
Bolsonaro faces a great wave of criticism for his handling of a pandemic that has spread throughout Brazil, the country with the second highest number of cases (2.6 million) and deaths (92,000) in the world.
Comparing the new virus to the “small flu,” Bolsonaro opposed quarantine measures and regularly broke safe distance rules by walking the streets of Brazil and shaking hands and hugging supporters.
After the outbreak, the virus was confirmed to the President on July 7. He quarantined the presidency for three weeks.
On Thursday, during the confirmation of his first public event since the infection, Bolsonaro greeted a group of supporters in the state of Piauj, in the northeast of the country, and took off his mask when he heard the screams.
The same day, the presidency announced that the virus had been infected by the president’s wife.
Bolsonaro later revealed he was feeling unwell again and said he was taking antibiotics for an infection he called “inflamed lungs,” allegedly caused by lack of activity during quarantine.
According to Mr. Bolsonar, quarantine measures are unnecessarily damaging to the economy.
Instead, he recommends using hydroxychloroquine to treat the virus, which he himself used to treat his infection, despite numerous studies showing that the drug does not have a positive effect against COVID-19.
No part of this publication may be reproduced without the written permission of ELTA.
[ad_2]
